Tekla Capital Management LLC - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 131 filers reported holding MIRATI THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.98 and the average weighting 0.6%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$2,366,154
-2.8%
65,4900.0%0.09%0.0%
Q1 2023$2,434,918
-17.9%
65,4900.0%0.09%
-17.0%
Q4 2022$2,967,352
-65.3%
65,490
-46.5%
0.11%
-68.0%
Q3 2022$8,548,000
+52.0%
122,390
+46.1%
0.35%
+58.4%
Q2 2022$5,624,000
-18.4%
83,7840.0%0.22%
-8.7%
Q1 2022$6,889,000
-43.9%
83,7840.0%0.24%
-38.7%
Q4 2021$12,290,000
-17.1%
83,7840.0%0.40%
-17.2%
Q3 2021$14,822,000
+9.5%
83,7840.0%0.48%
+8.4%
Q2 2021$13,534,000
-5.7%
83,7840.0%0.44%
-10.9%
Q1 2021$14,352,000
-22.0%
83,7840.0%0.49%
-23.6%
Q4 2020$18,402,000
+40.7%
83,784
+6.3%
0.65%
+32.0%
Q3 2020$13,082,000
+45.4%
78,7840.0%0.49%
+43.3%
Q2 2020$8,995,000
+48.5%
78,7840.0%0.34%
+24.8%
Q1 2020$6,056,000
-33.7%
78,784
+11.2%
0.27%
-20.6%
Q4 2019$9,133,000
+47.1%
70,873
-11.1%
0.34%
+27.3%
Q3 2019$6,208,000
+343.4%
79,687
+486.4%
0.27%
+375.4%
Q2 2019$1,400,000
+40.6%
13,5900.0%0.06%
+42.5%
Q1 2019$996,000
+72.9%
13,5900.0%0.04%
+60.0%
Q4 2018$576,000
-10.0%
13,5900.0%0.02%
+8.7%
Q3 2018$640,00013,5900.02%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$688,784,00067.42%
Avoro Capital Advisors LLC 4,535,000$996,067,00017.15%
Darwin Global Management, Ltd. 260,876$57,299,00015.99%
Boxer Capital, LLC 1,765,560$387,788,00012.46%
Perceptive Advisors 3,693,516$811,244,0008.71%
Consonance Capital Management LP 330,000$72,481,0006.77%
EcoR1 Capital, LLC 464,298$101,978,0005.48%
Fairmount Funds Management LLC 60,500$13,288,0004.75%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 67,400$14,804,0004.04%
RTW INVESTMENTS, LP 1,054,364$231,581,0003.88%
View complete list of MIRATI THERAPEUTICS INC shareholders